wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33830753-86BE229C-14E4-4106-857F-C2BFE124E3C6
Q33830753-86BE229C-14E4-4106-857F-C2BFE124E3C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33830753-86BE229C-14E4-4106-857F-C2BFE124E3C6
Ranibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: a meta-analysis of randomised controlled trials.
P2860
Q33830753-86BE229C-14E4-4106-857F-C2BFE124E3C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33830753-86BE229C-14E4-4106-857F-C2BFE124E3C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
60ccb223aa39a239ac7157b86c33f5b509281a3e
P2860
The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review.